Wednesday, June 29, 2016| Latest E-book
You are here:
Drugmakers
#

Drugmakers

Articles

Overweight Indian pharma stocks defy Asian market rout. Here's why

Sep 03, 2015

Overweight Indian pharma stocks defy Asian market rout. Here's why

So far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy's 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent #USFDA #Drugmakers #greenback #Indian pharma stocks #Asian rout #emerging market investors #MSCI Asia Pacific
US trade office reviewing SC ruling against Novartis

Apr 03, 2013

US trade office reviewing SC ruling against Novartis

The United States is considering its response to the Supreme Court ruling against Novartis, which US drug manufacturers warn is the latest sign of a "deteriorating" environment for intellectual property rights in India. #WhatNext #Novartis #big pharma #Drugmakers #US trade body
Novartis patent blow: Why Big Pharma can't quit India

Apr 03, 2013

Novartis patent blow: Why Big Pharma can't quit India

Much of the new business will still come from cheap generics made by local companies, but Western firms are also seeking to put their brands on unpatented medicines, prompting the likes of Abbott Laboratories and Daiichi Sankyo to buy up Indian companies. #TheLongView #Glenmark Generics Limited #Novartis #big pharma #Drugmakers
Govt panel proposes to regulate prices of patented drugs

Feb 27, 2013

Govt panel proposes to regulate prices of patented drugs

A panel formed under the ministry of chemicals and fertilizers has recommended setting up a committee to negotiate with drugmakers to fix prices of costly drugs used to treat deadly diseases such as cancer, HIV and hepatitis. #Cipla #PolicyWatch #Pharma #Abbott Laboratories #Drugmakers
Slow approvals put India's clinical trials at risk

Feb 13, 2013

Slow approvals put India's clinical trials at risk

Drugs firms complain that sluggish bureaucracy in New Delhi and a lack of legal clarity on how to conduct clinical trials have created a climate of regulatory uncertainty in the market. #HowThisWorks #Pharma #Drug trials #Litigataion #Drugmakers